The 2026 foodborne illness season produced the largest cyclosporiasis outbreak in U.S. history, a multistate Salmonella outbreak tied to imported jalapeños, and a recall of nearly 19 million shell eggs. Each event generated costs that extend well beyond the hospital bills of those who fell ill. The economic consequences, measured in lost sales, recalls, lawsuits, insurance claims, and regulatory response, have accumulated into a figure that public health researchers and industry analysts are still calculating.
The Baseline Burden
The federal government maintains a standing estimate of what foodborne illness costs the United States in a normal year. The USDA Economic Research Service’s most recent cost-of-foodborne-illness data product, based on 2023 dollars, puts the annual economic burden at approximately $75 billion, accounting for medical care, lost productivity, and premature deaths, including chronic conditions that develop after the initial illness. The Government Accountability Office, citing the same research, reported that this figure covers 31 pathogens and incorporates updated rates of chronic health problems caused by foodborne infections.
That $75 billion is an average. It does not describe what happens when a single pathogen escapes routine surveillance and enters a national supply chain. The 2026 cyclosporiasis outbreak, linked to iceberg lettuce processed by Taylor Farms de Mexico and served at Taco Bell locations in multiple states, sickened more than 12,000 people across 20 states and caused two deaths. The CDC recorded over 15,000 laboratory-confirmed cyclosporiasis cases by mid-August and that number continued to grow to nearly 20,000 by the time the outbreak was declared over in September.
Direct Market Losses: Produce and Restaurants
The economic damage from the cyclosporiasis outbreak began in the produce aisle. Market research firm Numerator, tracking purchase behavior across 200,000 U.S. households, reported that more than 6.5 million households stopped buying salad mixes and kits in the four weeks ending July 26. The firm estimated that approximately $280 million in produce spending was at risk every month the outbreak continued. In states where more than 200 cyclosporiasis cases had been reported, per-household spending on salad items dropped 10.7%.
The effects spread to crops that were never implicated in the outbreak. As reported by multiple sources, NielsenIQ data showed that from July 18 to August 8, sales of iceberg lettuce fell 25.4% and prepacked salads dropped 34.2%. Strawberry sales declined 14.7%, blackberries 16.4%, and raspberries 28.1% during overlapping periods. The Bureau of Labor Statistics recorded a 16.4% month-over-month decline in lettuce prices, the largest such drop on record.
Restaurant chains absorbed losses regardless of whether their suppliers were linked to the outbreak. Taco Bell’s same-store sales fell 2% in the July to September period, and traffic to the chain plummeted after the FDA linked its shredded lettuce to the outbreak. Sweetgreen, which was not implicated in the contamination, cut its full-year outlook and projected same-store sales declines of 7% to 8%, citing diner fears of eating fresh produce. The salad chain Salad and Go filed for Chapter 11 bankruptcy in August, with the cyclosporiasis outbreak worsening its existing financial challenges.
The Jalapeño Outbreak and Supply Chain Disruption
The Salmonella Javiana outbreak linked to jalapeño peppers grown in Sinaloa, Mexico, and distributed by Coast Citrus Distributors sickened 345 people across 27 states, with 36 hospitalizations. Chipotle Mexican Grill and QDOBA removed the peppers from their menus, and Taylor Farms recalled prepared items containing the peppers. The disruption rippled downstream when the USDA’s Food Safety and Inspection Service issued a public health alert for meat and poultry products containing the recalled jalapeños.
For a produce industry still recovering from the cyclosporiasis outbreak, the jalapeño contamination added a second layer of supply chain uncertainty. The recall was limited to a specific distributor, but industry analysts noted that any health incident translates into higher costs for producers, exporters, and logistics firms, in addition to temporary reputational damage. A Park County, Wyoming health officer, quoted by Cowboy State Daily, described the recurring nature of these events as “part of the cost of doing business for our industrialized society”.
The Egg Recall: A Case Study in Recall Economics
The July 2026 recall of shell eggs produced by Midwest Poultry Services illustrates how recall costs compound even when the affected product represents a small share of national supply. The company recalled more than 1.5 million dozen eggs, nearly 19 million individual eggs, sold under the Kroger, Simple Truth, Brookshire’s, Country Morning, and Cal-Maine Sunups brands. The FDA classified the recall as Class I, its highest-risk category, after the eggs were linked to a Salmonella Enteritidis outbreak that sickened at least 98 people and hospitalized 26.
Total shell egg stocks fell to 1,722,200 cases by late July, a new 2026 low and 13.2% below the year-to-date peak. The recall represented approximately 0.25% of monthly U.S. egg production, and analysts indicated that a widespread impact on egg prices was unlikely unless the recall expanded. But the costs to the producer are not limited to the value of the recalled product. Industry data puts the average direct cost of a food recall at approximately $10 million, and standard product liability insurance typically does not cover recall costs. Standalone product recall insurance policies typically carry limits of $1 million to $5 million with minimum premiums starting around $5,000, leaving a gap between average recall costs and available coverage.
Litigation and Insurance Exposure
The cyclosporiasis outbreak generated a wave of litigation against Taco Bell, its franchisees, and lettuce supplier Taylor Farms as case counts rose. Individual lawsuits illustrate the magnitude of economic and medical costs that outbreaks can generate. A Chicago man who alleged that eating contaminated food from Taco Bell caused an infection of cyclosporiasis. Despite sending his employer evidence of his situation, the company let him go. The man is suing Taco Bell and Taylor Farms for both the illness and loss of wages.
The insurance implications extend beyond the parties directly named in lawsuits. The property and casualty insurance industry has been monitoring the outbreak’s liability exposure, particularly as cases accumulated against multiple defendants across the supply chain. For food manufacturers, product recall insurance pricing remained favorable to buyers in the first quarter of 2026, but tariff-driven cost inflation and multi-hundred-million-dollar loss activity prompted calls for recall programs to be stress-tested for adequacy.
The Indirect Losses That Dominate
A 2026 study published in Food Policy provides the most rigorous available estimate of how food safety outbreaks affect markets beyond the direct recall costs. Researchers examined two multistate Salmonella outbreaks linked to fresh onions in 2020 and 2021, using household panel and retail scanner data. Onion purchases decreased by 20.37% in 2020 and 27.14% in 2021. Revenue losses totaled $1.158 billion in 2020 and $1.346 billion in 2021, exceeding the estimated upper bound of the annual U.S. health burden from all onion-related Salmonella cases, which the researchers placed at $680 million.
The study found that these indirect market losses were 25 to 100 times greater than direct recall costs, which amounted to $46.88 million in 2020 and $13.64 million in 2021. Producers absorbed nearly all losses in 2020 amid stable prices, while consumers bore an additional $201 million through 5.56% price increases in 2021. Retail assortment remained constant throughout both outbreaks, indicating that observed reductions in purchases were demand-driven rather than supply-constrained. The researchers concluded that “early outbreak warnings reduce illness but trigger broad consumption losses when sources remain unclear”.
The Cost-Benefit Calculus of Prevention
The disparity between prevention costs and outbreak costs has become a recurring theme in food safety policy discussions. The Microbiological Data Program, which tested approximately 15,000 produce samples annually and accounted for roughly 80% of federal produce pathogen testing before it was shut down in December 2012, cost $4.5 million per year. The USDA’s annual cost estimate for cyclosporiasis alone is $5.3 million, more than the entire national testing program cost.
The FDA’s own analysis of a proposed delay to the Food Traceability Rule provides another data point. When the agency proposed pushing the rule’s compliance date from January 2026 to July 2028, it estimated the forgone public health benefits of the delay at approximately $91 million to $112 million per year, against cost savings to industry of $54 million to $73 million. The arithmetic favored faster implementation on public health grounds, but the rule was delayed nonetheless.
These calculations exclude what the USDA’s cost estimates explicitly omit: pain and suffering, industry losses, and the cost of litigation and regulatory response. The agency states on its own data product page that its figures are conservative because they exclude willingness to pay to prevent non-financial harm. For an illness like cyclosporiasis that relapses in waves across weeks, that exclusion removes most of the injury from the calculation.
A Season That Exceeded the Model
By August 2026, the CDC had recorded over 15,000 laboratory-confirmed cyclosporiasis cases, with investigations spanning 47 states, the District of Columbia, and Puerto Rico. The produce industry faced a $280 million monthly spending risk. Restaurant chains not implicated in the outbreak reported declining sales. A salad chain filed for bankruptcy. Egg producers recalled nearly 19 million eggs. And the federal government’s baseline cost model, built on 2011 case counts and excluding industry losses, had been exceeded by a single outbreak in a single summer.
The economic question that remains unanswered is not whether prevention costs money. It is whether the current system’s reactive posture, testing, recalling, litigating, and rebuilding consumer confidence after each outbreak, costs more than the testing and traceability measures that public health researchers have recommended for years. The 2026 season has provided a substantial data set for that calculation. Whether it will be used is a policy decision, not an epidemiological one.
